Vcreate
Vcreate is in the process of developing the next generation of T-cell immunotherapies.
Vcreate is a business in biotechnology, founded in 2021.
The company sits in the biotechnology segment, where it competes on its core product or service.
The company is listed at the Pre_Seed stage of development.
Its team size is recorded as c_00001_00010 employees.
| Sector | Biotechnology |
|---|---|
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | pre_seed |
Website: vcreate.io
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account